REPLIGEN CORP

Profile

Company Names

REPLIGEN CORP

Addresses

41 SEYON STREET, SUITE 100, WALTHAM, MA 02453

41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA 02453

Phone Numbers

(781) 250-0111
781-250-0111

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, OTHER TECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$290,590,580.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-05-31 
$48,000,000.00 
$48,000,000.00 
$0.00 
Equity 
2
2017-08-01 
$238,590,580.00 
$238,590,580.00 
$0.00 
Equity 
1
2014-06-02 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NICOLAS 
 
BARTHELEMY 
DIRECTOR
REPLIGEN CORP   |  908 DEVICES INC.   |  NANOCELLECT BIOMEDICAL, INC.   |  SLINGSHOT BIOSCIENCES, INC.
NICOLAS 
M. 
BARTHELEMY 
DIRECTOR
LIFE TECHNOLOGIES CORP   |  REPLIGEN CORP
HOWARD 
 
BENJAMIN 
EXECUTIVE OFFICER
REPLIGEN CORP
GLENN 
L. 
COOPER 
DIRECTOR
CORONADO BIOSCIENCES INC   |  REPLIGEN CORP
JOHN 
G. 
COX 
DIRECTOR
REPLIGEN CORP   |  TORQUE THERAPEUTICS, INC.
KAREN 
A. 
DAWES 
DIRECTOR
REPLIGEN CORP
ALFRED 
L. 
GOLDBERG 
DIRECTOR
REPLIGEN CORP
MICHAEL 
A. 
GRIFFITH 
DIRECTOR
REPLIGEN CORP   |  INVENTIV HEALTH INC
WALTER 
C. 
HERLIHY 
EXECUTIVE OFFICER, DIRECTOR
REPLIGEN CORP
ANTHONY 
 
HUNT 
EXECUTIVE OFFICER
REPLIGEN CORP
TONY 
J. 
HUNT 
EXECUTIVE OFFICER, DIRECTOR
REPLIGEN CORP
RALF 
J. 
KURIYEL 
EXECUTIVE OFFICER
REPLIGEN CORP
GLENN 
P. 
MUIR 
DIRECTOR
HOLOGIC INC   |  REPLIGEN CORP   |  IMPULSE DYNAMICS PLC
JAMES 
R. 
RUSCHE 
EXECUTIVE OFFICER
REPLIGEN CORP
THOMAS 
F. 
RYAN , JR. 
DIRECTOR
REPLIGEN CORP
THOMAS 
F. 
RYAN, JR. 
DIRECTOR
REPLIGEN CORP
JON 
K. 
SNODGRES 
EXECUTIVE OFFICER
REPLIGEN CORP
DANIEL 
P. 
WITT 
EXECUTIVE OFFICER
REPLIGEN CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-06-13
D
Link
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-05-31 
2017-08-08
D
Link
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
2014-06-16
D
Link
OTHER TECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2014-06-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#